Ceramide AP

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Ceramide AP
Accession Number
DB14705
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 599.982
Monoisotopic: 599.548874455
Chemical Formula
C36H73NO5
Synonyms
  • Biomide 6
  • Ceramide 6
  • Ceramide 6 II
  • Ceramide VI
  • Cytomide VI
  • N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine
  • N-(2-hydroxyoctadecanoyl)-4R-hydroxysphinganine
  • N-(2-hydroxyoctadecanoyl)-hydroxysphinganine
  • N-(2-hydroxyoctadecanoyl)phytoceramide
  • N-(2-hydroxyoctadecanoyl)phytosphingosine
  • N-2-hydroxystearoyl-phytosphingosine
  • PHC-C 18:0/18:0
  • phytosphingosine-2-hydroxy-18:0

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
F1X8L2B00J
CAS number
212070-45-6
InChI Key
BBAFBDLICMHBNU-MFZOPHKMSA-N
InChI
InChI=1S/C36H73NO5/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-34(40)36(42)37-32(31-38)35(41)33(39)29-27-25-23-21-19-16-14-12-10-8-6-4-2/h32-35,38-41H,3-31H2,1-2H3,(H,37,42)/t32-,33+,34?,35-/m0/s1
IUPAC Name
2-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadecanamide
SMILES
CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC

References

General References
Not Available
ChemSpider
28533112
RxNav
1314307
ChEBI
67041

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000253 mg/mLALOGPS
logP8.36ALOGPS
logP10.01ChemAxon
logS-6.4ALOGPS
pKa (Strongest Acidic)12.7ChemAxon
pKa (Strongest Basic)-2.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area110.02 Å2ChemAxon
Rotatable Bond Count33ChemAxon
Refractivity176.87 m3·mol-1ChemAxon
Polarizability80.27 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on September 24, 2018 11:24 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates